Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...

Eli Lilly announced the results of a clinical trial for its new pill, which the company said causes nearly 8% weight loss at certain dosages.

Texas Senator Bryan Hughes introduced a bill that would require testing wastewater for mifepristone, raising abortion-rights ...

"Out of sight, out of mind" is how we often treat what is flushed down our toilets. But the drugs we take, from anxiety ...

Treatment for people living with HIV (antiretroviral ... However, there could be people who might find it difficult to take daily pills or those who want more choices of long-acting options.

Retaliatory measures could affect US drugs like MSD’s cancer treatment Keytruda and Eli Lilly’s injectable diabetes medicine Trulicity. Increased costs for European healthcare systems could ...

After Texas experienced the first measles death in the United States in a decade, Kennedy told Fox earlier this month that the federal government was delivering vitamin A—an unproven treatment ...

This relatively new treatment is called immunotherapy and I ... And although the first pill made Jude’s tongue tingle, he’s been fine with the tablets ever since. It’s still too early ...

Kidneys remove waste, extra fluid, and acids, maintaining a balance of water, salts, and minerals in the blood. They also regulate blood pressure, help make red blood cells, and are involved with ...

Eli Lilly (LLY) will soon be releasing trial data on its small-molecule GLP-1 weight-loss pill, Orforglipron. The drug could be pivotal for the obesity treatment market due to its accessibility.

It’s an oral pill called Blujepa from the London-based biopharma company ... of uUTIs caused by drug-resistant bacteria is increasing which can result in higher treatment failure rates,” GSK said in a ...